Crucell corporate brochure (PDF)
Crucell corporate brochure (PDF)
Crucell corporate brochure (PDF)
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
30<br />
Our business – Products<br />
MoRu-Viraten®<br />
MoRu-Viraten® is a safe, well-tolerated and effective vaccine for<br />
protection against measles and rubella in children, adolescents<br />
and adults. As MoRu-Viraten® is free of egg proteins and antibiotics,<br />
it can be safely used in children with allergies to these substances.<br />
The vaccine has been marketed since 1986 and is on the WHO list<br />
of vaccines for purchase by UN agencies.<br />
Epaxal® and Epaxal® Junior<br />
Virosomal adjuvanted Epaxal®is the only aluminum-free hepatitis A<br />
vaccine on the international market. The absence of aluminum reduces<br />
the pain associated with injection, making this vaccine especially<br />
suitable for children. A virosome is a biodegradable adjuvant system<br />
and provides a more natural presentation of the antigens than<br />
traditional adjuvants. Epaxal® induces protective antibody levels<br />
within 10 days after the initial injection. A second dose prolongs<br />
effective protection for an estimated 30 years or more. The booster<br />
dose is preferably injected 6–12 months after the first dose but<br />
may be given up to 10 years later.<br />
www.crucell.com<br />
Epaxal® is approved for use in adults and children from 1 year of age.<br />
The vaccine is currently licensed in more than 35 countries under the<br />
brand names Epaxal®, HAVpur®and VIROHEP-A.<br />
Vivotif®<br />
Vivotif® is a live attenuated oral vaccine for immunization of children and<br />
adults against typhoid fever. It is available as gastro-resistant capsules for<br />
oral administration. It is the only oral vaccine approved for protection<br />
against typhoid fever. The most common cause of this bacterial disease<br />
is Salmonella serotype Typhi (S. Typhi). The protective action starts<br />
about 10 days after the last dose is taken. Vivotif® is remarkably well<br />
tolerated, with post-marketing experience over more than 20 years<br />
confirming that adverse events are rare. Vivotif® typhoid fever vaccine is<br />
currently licensed in more than 30 countries, including the United States.<br />
Dukoral®<br />
Dukoral® oral inactivated cholera vaccine provides safe, effective<br />
and convenient protection against cholera for people living in at-risk
Change language